Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carrascosa

Showing results (231-240 of 242) with videos related to

Pageof 25
Sort By:
Actas Dermo-Sifiliograficas|March 19, 2023
BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early FindingsM Munera-Campos, P Chicharro, A Gonzalez Quesada, et al.
Actas Dermo-Sifiliograficas|October 11, 2025
[Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.
Actas Dermo-Sifiliograficas|May 12, 2023
[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early FindingsM Munera-Campos, P Chicharro, A Gonzalez Quesada, et al.
Actas Dermo-Sifiliograficas|March 2, 2025
Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.
Actas Dermo-Sifiliograficas|December 4, 2025
Characteristics, treatment, and safety profile of patients with atopic dermatitis according to eligibility for randomized clinical trials: an analysis from the Spanish Atopic Dermatitis Registry (BIOBADATOP)M Munera-Campos, A González Quesada, M Espasandín Arias, et al.
Actas Dermo-Sifiliograficas|June 1, 2024
[Translated article] Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)F J Navarro-Triviño, L Borrego, J F Silvestre-Salvador, et al.
Actas Dermo-Sifiliograficas|March 22, 2026
Health care resource utilization in patients with atopic dermatitis according to treatment response: evidence from the BIOBADATOP registryT Montero-Vilchez, S Arias-Santiago, R Sanabria-de la Torre, et al.
Actas Dermo-Sifiliograficas|May 16, 2026
Analysis of the Influence of Sex in 507 Patients With Moderate-to-Severe Atopic Dermatitis. Spanish Atopic Dermatitis Registry (BIOBADATOP)Alba Navarro-Bielsa, Y Gilaberte, J M Carrascosa, et al.
Actas Dermo-Sifiliograficas|February 12, 2025
[Translated article] Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP RegistryV Peris-Espino, M Munera-Campos, P Chicharro, et al.
Actas Dermo-Sifiliograficas|November 15, 2024
Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP RegistryV Peris-Espino, M Munera-Campos, P Chicharro, et al.
Pageof 25

Showing results (231-240 of 242) with videos related to

Sort By:
Pageof 25
Actas Dermo-Sifiliograficas|March 19, 2023
BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early FindingsM Munera-Campos, P Chicharro, A Gonzalez Quesada, et al.
Actas Dermo-Sifiliograficas|October 11, 2025
[Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.
Actas Dermo-Sifiliograficas|May 12, 2023
[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early FindingsM Munera-Campos, P Chicharro, A Gonzalez Quesada, et al.
Actas Dermo-Sifiliograficas|March 2, 2025
Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.
Actas Dermo-Sifiliograficas|December 4, 2025
Characteristics, treatment, and safety profile of patients with atopic dermatitis according to eligibility for randomized clinical trials: an analysis from the Spanish Atopic Dermatitis Registry (BIOBADATOP)M Munera-Campos, A González Quesada, M Espasandín Arias, et al.
Actas Dermo-Sifiliograficas|June 1, 2024
[Translated article] Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)F J Navarro-Triviño, L Borrego, J F Silvestre-Salvador, et al.
Actas Dermo-Sifiliograficas|March 22, 2026
Health care resource utilization in patients with atopic dermatitis according to treatment response: evidence from the BIOBADATOP registryT Montero-Vilchez, S Arias-Santiago, R Sanabria-de la Torre, et al.
Actas Dermo-Sifiliograficas|May 16, 2026
Analysis of the Influence of Sex in 507 Patients With Moderate-to-Severe Atopic Dermatitis. Spanish Atopic Dermatitis Registry (BIOBADATOP)Alba Navarro-Bielsa, Y Gilaberte, J M Carrascosa, et al.
Actas Dermo-Sifiliograficas|February 12, 2025
[Translated article] Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP RegistryV Peris-Espino, M Munera-Campos, P Chicharro, et al.
Actas Dermo-Sifiliograficas|November 15, 2024
Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP RegistryV Peris-Espino, M Munera-Campos, P Chicharro, et al.
Pageof 25